ArticleJournal of chemical information and modeling2026
SPECTRE: A Multimodal Spectral Transformer for Small Molecule Annotation.
Article in Journal of chemical information and modeling, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Development of new pharmaceuticals such as penicillin and numerous anticancer compounds often begins with the discovery and characterization of natural products (NPs). Nuclear magnetic resonance (NMR) spectroscopy is an essential tool for elucidating the chemical structure of NPs. However, interpreting NMR spectra is a time-consuming process that requires considerable domain expertise. This has led to the development of computational tools that directly annotate structures from NMR spectra, accelerating this elucidation and discovery process. Here we introduce SPECTRE, a state-of-the-art transformer-based model for structure dereplication and annotation. Key contributions of this tool include (1) a novel, transformer-based structure annotation method that accepts several types of NMR data for flexible annotation; (2) a novel, entropy-optimized, and collision-free molecular binary fingerprint that enhances the accuracy when retrieving molecular candidates. SPECTRE achieves a new state of the art 80% top-1 annotation accuracy using a challenging search space of 526,163 molecules. SPECTRE is also the first tool to provide fine-grained similarity maps between predicted and retrieved structures. These maps enable substructure-level interpretation, offering interpretable visual cues that highlight matched chemical fragments. Even in cases where overall molecular similarity is low, these fragment-level hints offer valuable insights to chemists, guiding hypothesis generation and accelerating the structure elucidation process.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.